Use of SGLT2 inhibitors may not increase fracture risk in patients with CKD

By Shawn M. Carter

While SGLT2 inhibitors are often associated with bone and mineral metabolism irregularities, it remains unclear if these are linked to higher fracture risk in patients with chronic kidney disease, according to recently published research. Read the full article in Healio.